Recent studies provide significant insights into NRF2 and BACH1 in tumor progression, including angiogenesis, tumor metabolism, endothelial-to-mesenchymal transition (EMT), and metastasis33–35,39–47, suggesting possible links between small MAFs and tumor progression. This evidence concerns the gene BACH1 and neoplasm.